Two biotechs emerged on Friday with assets from Keymed Biosciences, extending a proliferating trend of Western investors ...

City Therapeutics broke cover in October with a $135 million Series A and the opportunity for executive chairman John ...

Repare Therapeutics pauses gynecologic cancer drugs lunresertib & camonsertib, shifts focus to early-stage assets RP-1664 & ...

Boston-area startup Mediar Therapeutics is teaming up with Eli Lilly on a new drug for idiopathic pulmonary fibrosis. Lilly — one of the five large pharmas backing Mediar – will pay ...